Genenta Science S.p.A., a clinical-stage biotechnology company, develops hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company offers Temferon, which is in Phase 1/2a clinical trials for use in the t...
Q1 2026
Apr 1, 2026
FY 2025
Q3 2025
Oct 10, 2025
FY 2024
Mar 28, 2025
Q4 2024